Carlsbad CA
Carlsbad CA
At ROSE Diagnostics we have made it our mission to move the pathology lab in the cancer biopsy clinic with a suite of simple point of care diagnostic products to make cancer diagnostics work better .
Our products target cancer biopsy procedures where samples are collected from patients and sent to a pathology lab --- first for verification, and then for diagnoses.
ROSE Diagnostics is developing a panel of known lymph biomarkers in a rapid Point of Care test format
--- 5 minute turn-around-time allowing real-time actionable decisions
Disposable test cartridges are read on an affordable, small and portable reader already approved for other diagnostic products
At ROSE Diagnostics, we're at the forefront of medical research. Our team of experts is constantly pushing the boundaries of what's possible and developing new products that can improve patients' quality of life and make cancer diagnostics work better.
We believe that the best results come from working together. That's why we collaborate with other research institutions, medical centres, and pharmaceutical companies to achieve our goals. We have partnered with world-leading organizations.
If you are interested in becoming a clinical partner please us the contact us link at the bottom.
Our world-class product development facilities in Carlsbad CA provide the perfect environment for conducting research and developing new
verifi-dx™ testing products. Equipped with the latest technology and equipment, we're able to develop products that achieve new levels of speed accuracy and precision.
At ROSE Diagnostics, we put patients at the centre of everything we do. Our research is designed to improve patients' lives and provide better treatment options for a wide range of medical conditions.
Our team of experienced researchers and medical professionals is dedicated to advancing the field of medicine. We bring a diverse range of skills and expertise to every project.
We're always looking for new and innovative ways to approach medical research. Our team is constantly exploring new technologies, techniques, and approaches to achieve our goals.
Our products target cancer biopsy procedures where samples are collected from patients and sent to a pathology lab --- first for verification, and then for diagnoses.
Our first mission is to commercialize a biopsy sample screening test for lung cancer.
• Current verifi™ LUNG Test TAT is ~ 5 minutes
• Multiplexed using a dynamic predictive algorithm
• Sandwiched immunoassay, lateral flow format
• Qualitative result (Y/N) with semi-quant capabilities
• Perfect for EBUS-TBNA or EUS-FNA procedures
NOT FDA Cleared or approved in any jurisdiction.
ROSE Diagnostics is committed to building strong relationships with our future clinical partners and customers.
If you are interested in learning more about our verifi LUNG Test currently in development and our clinical study program, please submit your contact information below and a member of our Clinical Team will reach out to you.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.